Hikal Limited
NSE: HIKAL · Healthcare
₹208.37
-3.62 (-1.71%)
Last close · 30 Aug 2026, 2:51 am IST
- Open
- ₹212.10
- Day high
- ₹212.91
- Day low
- ₹205.81
- Volume
- 1.69 L
- Prev close
- ₹211.99
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 2,681 Cr
- Price
- 217.40
- P/E (TTM)
- -54.90
- P/E (Fwd)
- 24.16
- P/B
- 2.23
- EV/EBITDA
- —
- EV/Revenue
- —
- PEG
- —
- Div Yield
- 0.46%
- 52W High
- 336.50
- 52W Low
- 146.25
- Beta
- —
Profitability & income
- Revenue (TTM)
- 1,204 Cr
- Net Income (TTM)
- 74 Cr
- EBITDA
- 224 Cr
- Gross Margin
- 47.01%
- Op. Margin
- 13.16%
- Net Margin
- 6.15%
- ROE
- -4.07%
- ROA
- -2.06%
- EPS (TTM)
- -3.96
- EPS (Fwd)
- 9.00
Financial health
- Total Debt
- 684 Cr
- Total Cash
- 10 Cr
- Debt/Equity
- 57.04
- Current Ratio
- —
- Quick Ratio
- —
- Book Value
- 97.40
- Free Cash Flow
- 154 Cr
- Op. Cash Flow
- 302 Cr
Growth
- Revenue Growth
- 37.30%
- Earnings Growth
- 68.30%
- Earnings QoQ
- 68.00%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 517 Cr | 14 Cr | 65 Cr | 63 Cr | 300 Cr | — | 684 Cr | 1,199 Cr |
| 2025-12-31 | 491 Cr | -6 Cr | 48 Cr | 42 Cr | 259 Cr | — | — | — |
| 2025-09-30 | 316 Cr | -35 Cr | 9 Cr | -34 Cr | 190 Cr | — | 683 Cr | 1,194 Cr |
| 2025-06-30 | 371 Cr | -22 Cr | 26 Cr | -14 Cr | 185 Cr | — | — | — |
| 2025-03-31 | 550 Cr | 50 Cr | 124 Cr | 86 Cr | 318 Cr | — | 765 Cr | 1,262 Cr |
| 2024-12-31 | — | — | — | — | — | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,695 Cr | -49 Cr | 148 Cr | 57 Cr | 934 Cr | 302 Cr | 684 Cr | 1,199 Cr |
| 2025-03-31 | 1,844 Cr | 91 Cr | 333 Cr | 194 Cr | 1,006 Cr | 280 Cr | 765 Cr | 1,262 Cr |
| 2024-03-31 | 1,769 Cr | 70 Cr | 266 Cr | 150 Cr | 905 Cr | 187 Cr | 818 Cr | 1,188 Cr |
| 2023-03-31 | 2,005 Cr | 78 Cr | 255 Cr | 149 Cr | 862 Cr | 315 Cr | 748 Cr | 1,133 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for HIKAL?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in